Physicians' Academy for Cardiovascular Education

LDL cholesterol, the LDL receptor pathway & PCSK9

Sep. 10, 2016

Educational information

A mechanism of action animation on the potential role of the inhibition of PCSK9 with a monoclonal antibody.

Disclosure

Provided as an educational service by Regeneron /Sanofi

Share this page with your colleagues and friends: